News Heidelberg Pharma AG Deutsche Boerse AG

Equities

HPHA

DE000A11QVV0

Market Closed - Deutsche Boerse AG Other stock markets 03:49:58 2024-04-19 pm EDT			5-day change	1st Jan Change
2.96 ^EUR	-0.34%		-0.34%	-18.90%

Mar. 27	Heidelberg Pharma Wins US FDA Orphan Drug Designation for Multiple Myeloma Treatment	MT
Mar. 25	Transcript : Heidelberg Pharma AG, 2023 Earnings Call, Mar 25, 2024

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

DD: Heidelberg Pharma AG: Walter Miller, buy	Apr. 17	EQ
Heidelberg Pharma to host R&D Webinar following novel data presented at AACR	Apr. 05	EQ
PM: Heidelberg Pharma receives Orphan Drug Designation from the FDA for its ATAC candidate HDP-101	Mar. 28	AQ
Heidelberg Pharma Wins US FDA Orphan Drug Designation for Multiple Myeloma Treatment	Mar. 27	MT
Heidelberg Pharma granted orphan drug designation by FDA for its proprietary ATAC candidate HDP-101	Mar. 27	EQ
DD: Heidelberg Pharma AG: Dr. Georg F. Baur, buy	Mar. 26	EQ
Heidelberg Pharma : Presentation Analyst and Press Conference 2024	Mar. 25	PU
Heidelberg Pharma : Präsentation Bilanzpressekonferenz 2024	Mar. 25	PU
Transcript : Heidelberg Pharma AG, 2023 Earnings Call, Mar 25, 2024	Mar. 25
Heidelberg Pharma announces financial figures and reports on successful business performance in 2023	Mar. 25	EQ
Heidelberg Pharma AG Reports Earnings Results for the Full Year Ended November 30, 2023	Mar. 24	CI
Heidelberg Pharma : Presentation	Mar. 21	PU
Heidelberg Pharma Concludes Royalty Purchase Deal with HealthCare Royalty	Mar. 19	MT
Heidelberg Pharma announces receipt of non-refundable upfront cash payment following the successful closing of its royalty purchase agreement with HealthCare Royalty	Mar. 19	EQ
Heidelberg Pharma : Statement on Corporate Governance 2023 as of 19 March 2024	Mar. 18	PU
Heidelberg Pharma announces progress into Cohort 6 with its proprietary ATAC candidate HDP-101 in Phase I/IIa multiple myeloma study	Mar. 18	EQ
PM, Heidelberg Pharma Presents Initial Efficacy Data on HDP-101 and Data from Proprietary ADC Technology Platform at AACR 2024 Meeting	Mar. 07	AQ
Heidelberg Pharma to Present First Efficacy Data on HDP-101 and Data from Proprietary ADC Technology Platform at AACR Meeting 2024	Mar. 06	EQ
Heidelberg Pharma Announces Royalty Financing Agreement with HealthCare Royalty for up to USD 115 million	Mar. 04	EQ
Heidelberg Pharma Announces Royalty Financing Agreement with HealthCare Royalty for up to USD 115 million	Mar. 04	EQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Heidelberg Pharma AG Deutsche Boerse AG

Equities

HPHA

DE000A11QVV0

Summary

Filters